SEC Form 4 · accession 0001104659-15-016988
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Patrick
Officer — VP, Chief Financial Officer
Period of report
Mar 3, 2015
Accepted (ET)
Mar 5, 2015 · 10:36 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 12,434 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $9.13 | Mar 3, 2015 | A | 50,000 | A | — | Mar 3, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Includes an aggregate of 1,332 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.
- F2The option vests in four equal annual installments beginning on March 3, 2016.